The roles of platelet-derived growth factors and their receptors in brain radiation necrosis

Radiation Oncology

Volumn 9, Issue 1, 2014, Pages

  Miyata, Tomo ^a   Toho, Taichiro ^a   Nonoguchi, Naosuke ^a   Furuse, Motomasa ^a   Kuwabara, Hiroko ^a   Yoritsune, Erina ^a   Kawabata, Shinji ^a   Kuroiwa, Toshihiko ^a   Miyatake, Shin Ichi ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Angiogenesis; Brain radiation necrosis; Inflammation; Platelet derived growth factor receptors; Platelet derived growth factors

Indexed keywords

ADOLESCENT; ADULT; AGED; BRAIN; BRAIN NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NECROSIS; PLATELET-DERIVED GROWTH FACTOR; RADIATION INJURIES; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR;

EID: 84894073356     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-9-51     Document Type: Article

References (30)

1. Nonoguchi N, Miyatake S, Fukumoto M, Furuse M, Hiramatsu R, Kawabata S, Kuroiwa T, Tsuji M, Ono K. The distribution of vascular endothelial growth factor-producing cells in clinical radiation necrosis of the brain: pathological consideration of their potential roles. J Neurooncol 2011, 105:423-431. 10.1007/s11060-011-0610-9, 21688077.
2. Giglio P, Gilbert MR. Cerebral radiation necrosis. Neurologist 2003, 9:180-188. 10.1097/01.nrl.0000080951.78533.c4, 12864928.
3. Glantz MJ, Burger PC, Friedman AH, Radtke RA, Massey EW, Schold SC. Treatment of radiation-induced nervous system injury with heparin and warfarin. Neurology 1994, 44:2020-2027. 10.1212/WNL.44.11.2020, 7969953.
4. Levin VA, Bidaut L, Hou P, Kumar AJ, Wefel JS, Bekele BN, Grewal J, Prabhu S, Loghin M, Gilbert MR, Jackson EF. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys 2011, 79:1487-1495. 10.1016/j.ijrobp.2009.12.061, 2908725, 20399573.
5. Furuse M, Nonoguchi N, Kawabata S, Yoritsune E, Takahashi M, Inomata T, Kuroiwa T, Miyatake S. Bevacizumab treatment for symptomatic radiation necrosis diagnosed by amino acid PET. Jpn J Clin Oncol 2013, 43:337-341. 10.1093/jjco/hys231, 23303838.
6. Miyatake SI, Furuse M, Kawabata S, Maruyama T, Kumabe T, Kuroiwa T, Ono K. Bevacizumab treatment of symptomatic pseudoprogression after boron neutron capture therapy for recurrent malignant gliomas. Report of 2 cases. Neuro-oncology 2013, 15:650-655.
7. Furuse M, Kawabata S, Kuroiwa T, Miyatake S. Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases. J Neurooncol 2011, 102:471-475. 10.1007/s11060-010-0333-3, 20694573.
8. Arbab AS, Janic B, Jafari-Khouzani K, Iskander AS, Kumar S, Varma NR, Knight RA, Soltanian-Zadeh H, Brown SL, Frank JA. Differentiation of glioma and radiation injury in rats using in vitro produce magnetically labeled cytotoxic T-cells and MRI. PLoS One 2010, 5:e9365. 10.1371/journal.pone.0009365, 2829084, 20195476.
9. Kumar S, Arbab AS, Jain R, Kim J, deCarvalho AC, Shankar A, Mikkelsen T, Brown SL. Development of a novel animal model to differentiate radiation necrosis from tumor recurrence. J Neurooncol 2012, 108:411-420. 10.1007/s11060-012-0846-z, 3369018, 22407176.
10. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999, 79:1283-1316.
11. Heldin CH, Ostman A, Ronnstrand L. Signal transduction via platelet-derived growth factor receptors. Biochim Biophys Acta 1998, 1378:F79-F113.
12. Bergsten E, Uutela M, Li X, Pietras K, Ostman A, Heldin CH, Alitalo K, Eriksson U. PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor. Nat Cell Biol 2001, 3:512-516. 10.1038/35074588, 11331881.
13. Li X, Ponten A, Aase K, Karlsson L, Abramsson A, Uutela M, Backstrom G, Hellstrom M, Bostrom H, Li H, et al. PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. Nat Cell Biol 2000, 2:302-309. 10.1038/35010579, 10806482.
14. Wang Z, Ahmad A, Li Y, Kong D, Azmi AS, Banerjee S, Sarkar FH. Emerging roles of PDGF-D signaling pathway in tumor development and progression. Biochim Biophys Acta 1806, 2010:122-130.
15. Lei H, Kazlauskas A. Focus on molecules: platelet-derived growth factor C, PDGF-C. Exp Eye Res 2008, 86:711-712. 10.1016/j.exer.2007.08.007, 2712726, 17904120.
16. Wang Z, Kong D, Banerjee S, Li Y, Adsay NV, Abbruzzese J, Sarkar FH. Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling. Cancer Res 2007, 67:11377-11385. 10.1158/0008-5472.CAN-07-2803, 18056465.
17. Hoch RV, Soriano P. Roles of PDGF in animal development. Development 2003, 130:4769-4784. 10.1242/dev.00721, 12952899.
18. Li R, Maminishkis A, Wang FE, Miller SS. PDGF-C and -D induced proliferation/migration of human RPE is abolished by inflammatory cytokines. Invest Ophthalmol Vis Sci 2007, 48:5722-5732. 10.1167/iovs.07-0327, 18055825.
19. Lindahl P, Johansson BR, Leveen P, Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 1997, 277:242-245. 10.1126/science.277.5323.242, 9211853.
20. Li X, Kumar A, Zhang F, Lee C, Li Y, Tang Z, Arjuna P. VEGF-independent angiogenic pathways induced by PDGF-C. Oncotarget 2010, 1:309-314. 2944232,2944232, 20871734.
21. Uutela M, Wirzenius M, Paavonen K, Rajantie I, He Y, Karpanen T, Lohela M, Wiig H, Salven P, Pajusola K, et al. PDGF-D induces macrophage recruitment, increased interstitial pressure, and blood vessel maturation during angiogenesis. Blood 2004, 104:3198-3204. 10.1182/blood-2004-04-1485, 15271796.
22. Deuel TF, Senior RM, Huang JS, Griffin GL. Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J Clin Invest 1982, 69:1046-1049. 10.1172/JCI110509, 370161, 7076844.
23. Kumagai S, Ohtani H, Nagai T, Funa K, Hiwatashi N, Shimosegawa T, Nagura H. Platelet-derived growth factor and its receptors are expressed in areas of both active inflammation and active fibrosis in inflammatory bowel disease. Tohoku J Exp Med 2001, 195:21-33. 10.1620/tjem.195.21, 11780721.
24. Leibovich SJ, Ross R. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol 1975, 78:71-100. 1915032, 1109560.
25. Gilbertson DG, Duff ME, West JW, Kelly JD, Sheppard PO, Hofstrand PD, Gao Z, Shoemaker K, Bukowski TR, Moore M, et al. Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor. J Biol Chem 2001, 276:27406-27414. 10.1074/jbc.M101056200, 11297552.
26. Cao R, Brakenhielm E, Li X, Pietras K, Widenfalk J, Ostman A, Eriksson U, Cao Y. Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and -alphabeta receptors. FASEB J 2002, 16:1575-1583. 10.1096/fj.02-0319com, 12374780.
27. LaRochelle WJ, Jeffers M, Corvalan JR, Jia XC, Feng X, Vanegas S, Vickroy JD, Yang XD, Chen F, Gazit G, et al. Platelet-derived growth factor D: tumorigenicity in mice and dysregulated expression in human cancer. Cancer Res 2002, 62:2468-2473.
28. Li H, Fredriksson L, Li X, Eriksson U. PDGF-D is a potent transforming and angiogenic growth factor. Oncogene 2003, 22:1501-1510. 10.1038/sj.onc.1206223, 12629513.
29. Zhao L, Zhang C, Liao G, Long J. RNAi-mediated inhibition of PDGF-D leads to decreased cell growth, invasion and angiogenesis in the SGC-7901 gastric cancer xenograft model. Cancer Biol Ther 2010, 9:42-48. 10.4161/cbt.9.1.10282, 20087065.
30. Ungvari Z, Podlutsky A, Sosnowska D, Tucsek Z, Toth P, Deak F, Gautam T, Csiszar A, Sonntag WE. Ionizing radiation promotes the acquisition of a senescence-associated secretory phenotype and impairs angiogenic capacity in cerebromicrovascular endothelial cells: role of increased DNA damage and decreased DNA repair capacity in microvascular radiosensitivity. J Gerontol Series A, Biol Sci Med Sci 2013, 68:1443-1457.